subscribeSubscribe
price-trendAsk Us
UCB`s second shot at Neupro patent validation fails on appeal

UCB`s second shot at Neupro patent validation fails on appeal
Nick Paul Taylor FIERCE PHARMA
13 Apr 2023
Share Share
XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson

XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson
ACCESSWIRE
18 Oct 2022
Share Share
XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD

XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD
ACCESSWIRE
09 May 2022
Share Share
XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD

XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD
ACCESSWIRE
04 Apr 2022
Share Share
XPhyto Reports Development Update for its Drug Delivery Business

XPhyto Reports Development Update for its Drug Delivery Business
ACCESSWIRE
12 Oct 2021
Share Share
Letters and drug alerts sent to healthcare professionals in July 2019

Letters and drug alerts sent to healthcare professionals in July 2019
GOVUK
19 Aug 2019
Share Share
Watchdog sues FDA for stalling on Parkinson`s drug warnings

Watchdog sues FDA for stalling on Parkinson`s drug warnings
Kyle Blankenship FIERCE PHARMA
01 May 2019
Share Share
China FDA ahead for UCB`s Neupro after PhIII Parkinson`s results

China FDA ahead for UCB`s Neupro after PhIII Parkinson`s results
EJ Lane FIERCE PHARMA ASIA
18 Jun 2015
Share Share